Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
264.56
-3.34 (-1.25%)
Aug 17, 2026, 4:00 PM EDT - Market closed
Tenet Healthcare Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 21,812 | 21,310 | 20,675 | 20,564 | 19,174 | 19,485 |
Revenue Growth | 5.41% | 3.07% | 0.54% | 7.25% | -1.60% | 10.46% |
Gross Profit Gross Profit Growth | 9,087 | 8,817 | 8,219 | 7,821 | 7,048 | 7,268 |
Operating Income Operating Income Growth | 3,951 | 3,772 | 3,218 | 2,805 | 2,485 | 2,562 |
Net Income Net Income Growth | 2,241 | 1,407 | 3,200 | 611 | 411 | 914 |
Earnings Per Share EPS Growth | 25.75 | 15.49 | 32.70 | 5.71 | 3.78 | 8.42 |
EPS Growth | 64.50% | -52.63% | 473.12% | 50.87% | -55.07% | 124.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Ambulatory Care Ambulatory Care Growth | 5,416 | 5,172 | 4,534 | 3,865 | 3,248 | 2,718 |
Hospital Operations and Services Hospital Operations and Services Growth | 16,396 | 16,138 | 16,141 | 16,683 | 15,926 | 16,767 |
Revenue (Total) Revenue (Total) Growth | 22,638 | 21,310 | 20,675 | 20,564 | 19,368 | 19,676 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,170 | 2,942 | 3,069 | 1,276 | 888 | 2,364 |
Total Debt Total Debt Growth | 13,248 | 14,428 | 14,327 | 16,213 | 16,332 | 16,771 |
Net Cash (Debt) Net Cash Growth | -11,078 | -11,486 | -11,258 | -14,937 | -15,444 | -14,407 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -127.31 | -126.45 | -115.02 | -142.53 | -139.74 | -132.70 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,015 | 3,540 | 2,047 | 2,374 | 1,083 | 1,568 |
Capital Expenditures CapEx Growth | -992 | -1,010 | -931 | -751 | -762 | -658 |
Free Cash Flow Free Cash Flow Growth | 3,023 | 2,530 | 1,116 | 1,623 | 321 | 910 |
Free Cash Flow Growth | 94.66% | 126.70% | -31.24% | 405.61% | -64.72% | -68.26% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.66% | 41.38% | 39.75% | 38.03% | 36.76% | 37.30% |
Operating Margin | 18.11% | 17.70% | 15.57% | 13.64% | 12.96% | 13.15% |
Pretax Margin | 17.72% | 13.14% | 25.38% | 7.86% | 7.01% | 9.69% |
Profit Margin | 10.27% | 6.60% | 15.48% | 2.97% | 2.14% | 4.69% |
FCF Margin | 13.86% | 11.87% | 5.40% | 7.89% | 1.67% | 4.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.27 | 12.41 | 3.75 | 12.56 | 12.84 | 9.57 |
Forward PE | 12.84 | 12.20 | 11.76 | 13.40 | 9.55 | 13.95 |
P/FCF Ratio | 7.05 | 6.90 | 10.76 | 4.73 | 16.43 | 9.62 |
PS Ratio | 0.98 | 0.82 | 0.58 | 0.37 | 0.28 | 0.45 |